BCAL Diagnostics Limited (BDX.AX)
AUD 0.09
(6.9%)
AUD 0.09
(6.9%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 8.54 Million AUD | 8.19% |
| 2023 | 7.89 Million AUD | 92.45% |
| 2022 | 4.1 Million AUD | 127.98% |
| 2021 | 1.8 Million AUD | 59.21% |
| 2020 | 1.13 Million AUD | 66.39% |
| 2019 | 679.55 Thousand AUD | -1.55% |
| 2018 | 690.24 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 2.36 Million AUD | -39.99% |
| 2024 Q2 | 3.94 Million AUD | 87.22% |
| 2024 FY | 8.81 Million AUD | 11.65% |
| 2024 Q1 | 2.1 Million AUD | -52.32% |
| 2024 Q4 | 2.36 Million AUD | 0.0% |
| 2023 FY | 7.89 Million AUD | 92.45% |
| 2023 Q4 | 4.41 Million AUD | 100.0% |
| 2023 Q3 | 2.2 Million AUD | -36.47% |
| 2023 Q2 | 3.47 Million AUD | 101.22% |
| 2023 Q1 | 1.72 Million AUD | -26.69% |
| 2022 Q3 | 1.18 Million AUD | -31.08% |
| 2022 FY | 4.1 Million AUD | 127.98% |
| 2022 Q2 | 1.72 Million AUD | 100.0% |
| 2022 Q1 | 862.78 Thousand AUD | -41.72% |
| 2022 Q4 | 2.35 Million AUD | 98.27% |
| 2021 Q4 | 1.48 Million AUD | 100.0% |
| 2021 FY | 1.8 Million AUD | 59.21% |
| 2021 Q1 | 159.88 Thousand AUD | -75.07% |
| 2021 Q2 | 319.77 Thousand AUD | 100.0% |
| 2021 Q3 | 740.22 Thousand AUD | 131.49% |
| 2020 Q3 | 320.65 Thousand AUD | -35.5% |
| 2020 Q1 | 248.57 Thousand AUD | 0.0% |
| 2020 Q4 | 641.31 Thousand AUD | 100.0% |
| 2020 Q2 | 497.14 Thousand AUD | 100.0% |
| 2020 FY | 1.13 Million AUD | 66.39% |
| 2019 FY | 679.55 Thousand AUD | -1.55% |
| 2018 FY | 690.24 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Australian Clinical Labs Limited | 81.54 Million AUD | 89.521% |
| Genetic Signatures Limited | 4.3 Million AUD | -98.358% |
| Genetic Technologies Limited | 3.9 Million AUD | -118.859% |
| Healius Limited | 265.1 Million AUD | 96.777% |
| Imagion Biosystems Limited | 15.53 Million AUD | 44.991% |
| Integral Diagnostics Limited | 61.88 Million AUD | 86.193% |
| INOVIQ Ltd | 6.8 Million AUD | -25.541% |
| Microba Life Sciences Limited | 5.9 Million AUD | -44.702% |
| Monash IVF Group Limited | 91.1 Million AUD | 90.621% |
| Rhythm Biosciences Limited | 5.34 Million AUD | -59.729% |
| Sonic Healthcare Limited | 1.49 Billion AUD | 99.429% |